Abstract
A high percentage of critical patients are found to develop acute respiratory distress syndrome (ARDS). Several studies have reported high mortality rates in these cases which are most frequently associated with multiple organ dysfunctions syndrome. Lately, many efforts have been made to evaluate and monitor ARDS in critical patients. In this regard, the assessment of genetic polymorphisms responsible for developing ARDS present as a challenge and are considered future biomarkers. Early detection of the specific polymorphic gene responsible for ARDS in critically ill patients can prove to be a useful tool in the future, able to help decrease the mortality rates in these cases. Moreover, identifying the genetic polymorphism in these patients can help in the implementation of a personalized intensive therapy scheme for every type of patient, based on its genotype.
Similar content being viewed by others
Abbreviations
- ARDS:
-
Acute respiratory distress syndrome
- MODS:
-
Multiple organ dysfunction syndrome
- ICU:
-
Intensive care unit
- VEGF:
-
Vascular endothelial growth factor
- SIRS:
-
Systemic inflammatory response syndrome
- IL-8:
-
Interleukin 8
- BALF:
-
Bronchoalveolar lavage fluid
- IL-1β:
-
Interleukin 1 beta
- ENA-78:
-
Epithelial cell neutrophil activator 78
- MIP-1α:
-
Macrophage inflammatory peptide-1 alpha
- TNF-α:
-
Tumor necrosis factor alpha
- LPS:
-
Lipopolysaccharide
- HMGB1:
-
High mobility group box 1
- PECAM-1:
-
Platelet entothelial cell adhesion molecule-1
- MBL:
-
Mannose binding lectin
- HO-1:
-
Heme-oxygenase-1
- PC:
-
Activated protein C
- TM:
-
Thrombomodulin
- EPCR:
-
Endothelial protein C receptor
- HIF-1α:
-
Hypoxia-inducible factor 1 alpha
References
Ahasic AM, Zhao Y, Su L et al (2014) Adiponectin gene polymorphisms and acute respiratory distress syndrome susceptibility and mortality. PLoS ONE 9:e89170. doi:10.1371/journal.pone.0089170
Azevedo ZM, Moore DB, Lima FC et al (2012) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients. Hum Immunol 73:661–667. doi:10.1016/j.humimm.2012.03.007
Blondonnet R, Constantin J, Sapin V, Jabaudon M (2016) A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016:3501373. doi:10.1155/2016/3501373
Dal-Cim T, Molz S, Egea J et al (2012) Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway. Neurochem Int 61:397–404. doi:10.1016/j.neuint.2012.05.021
Entezari M, Javdan M, Antoine DJ et al (2014) Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biol 2:314–322. doi:10.1016/j.redox.2014.01.013
Fioretto JR, De Carvalho WB (2013) Temporal evolution of acute respiratory distress syndrome definitions. J Pediatr (Rio J) 89:523–530. doi:10.1016/j.jped.2013.02.023
Gómez-Caro A, Badia JR, Ausin P (2010) Extracorporeal lung assist in severe respiratory failure and ARDS. Current situation and clinical applications. Arch Bronconeumol 46:531–537. doi:10.1016/S1579-2129(11)60006-2
Goodman RB, Pugin J, Lee JS, Matthay MA (2003) Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14:523–535. doi:10.1016/S1359-6101(03)00059-5
Hildebrand F, Mommsen P, Frink M et al (2011) Genetic predisposition for development of complications in multiple trauma patients. Shock 35:440–448. doi:10.1097/SHK.0b013e31820e2152
Höcker A, Rabeling M, Bick A et al (2015) Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trial. BMC Anesthesiol 16:61. doi:10.1186/s12871-016-0225-y
Kangelaris KN, Sapru A, Calfee CS et al (2012) The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest 141:1160–1169. doi:10.1378/chest.11-1766
Liu L, Ning B (2015) The role of MBL2 gene polymorphism in sepsis incidence. Int J Clin Exp Pathol 8:15123–15127
Mahmood I, Tawfeek Z, El-menyar A et al (2015) Outcome of concurrent occult hemothorax and pneumothorax in trauma patients who required assisted ventilation. Emerg Med Int 2015:1–6. doi:10.1155/2015/859130
Matsuda A, Kishi T, Jacob A et al (2012) Association between insertion/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome: a meta-analysis. BMC Med Genet 13:76. doi:10.1186/1471-2350-13-76
Medford AR, Millar AB (2006) Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome: paradox or paradigm? Thorax 61:621–626. doi:10.1159/000356034
Medford ARL, Ibrahim NBN, Millar AB (2009) Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome. J Crit Care 24:236–242. doi:10.1016/j.jcrc.2008.04.003
Moradi M, Mojtahedzadeh M, Mandegari A et al (2009) The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med 103:434–441. doi:10.1016/j.rmed.2008.09.013
Namba F, Go H, Murphy JA et al (2014) Expression level and subcellular localization of heme oxygenase-1 modulates its cytoprotective properties in response to lung injury: a mouse model. PLoS ONE 9:1–11. doi:10.1371/journal.pone.0090936
Nathens AB, Neff MJ, Jurkovich GJ et al (2002) Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236:814–822. doi:10.1097/00000658-200212000-00014
O’Mahony DS, Glavan BJ, Holden TD et al (2012) Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS ONE 7:1–9. doi:10.1371/journal.pone.0051104
Sapru A, Liu KD, Wiemels J et al (2016) Association of common genetic variation in the protein C pathway genes with clinical outcomes in acute respiratory distress syndrome. Crit Care 20:151. doi:10.1186/s13054-016-1330-5
Schroeder JE, Weiss YG, Mosheiff R (2009) The current state in the evaluation and treatment of ARDS and SIRS. Injury 40:S82–S89. doi:10.1016/j.injury.2009.10.041
Sun W, Li FS, Zhang YH et al (2015) Association of susceptibility to septic shock with platelet endothelial cell adhesion molecule-1 gene Leu125Val polymorphism and serum sPECAM-1 levels in sepsis patients. Int J Clin Exp Med 8:20490–20498
Tejera P, Meyer NJ, Chen F et al (2012) Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet 49:671–680. doi:10.1136/jmedgenet-2012-100972
Tsangaris I, Tsantes A, Bonovas S et al (2009) The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res 123:832–836. doi:10.1016/j.thromres.2008.07.018
Wada T, Jesmin S, Gando S et al (2013) The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with critical illness. J Inflamm (Lond) 10:6. doi:10.1186/1476-9255-10-6
Williams AE, Chambers RC (2014) The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol 306:L217–L230. doi:10.1152/ajplung.00311.2013
Xu Z, Huang Y, Mao P et al (2015) Sepsis and ARDS: the dark side of histones. Mediators Inflamm 2015:205054. doi:10.1155/2015/205054
Zhai R, Gong MN, Zhou W et al (2007) Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 62:718–722. doi:10.1136/thx.2006.069393
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Horhat, F.G., Gundogdu, F., David, L.V. et al. Early Evaluation and Monitoring of Critical Patients with Acute Respiratory Distress Syndrome (ARDS) Using Specific Genetic Polymorphisms. Biochem Genet 55, 204–211 (2017). https://doi.org/10.1007/s10528-016-9787-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-016-9787-0